Duchenne muscular dystrophy: RNA-based therapeutics and microRNA biology

Duchenne muscular dystrophy: RNA-based therapeutics and microRNA biology

<p>Duchenne muscular dystrophy (DMD) is a progressive muscle wasting disorder caused by absence of functional dystrophin protein. This thesis describes investigations into the role of small non-coding RNAs in both DMD pathology, and as potential therapeutic molecules.</p> <p>MicroR...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Roberts, T
Rannpháirtithe:	Wood, M
Formáid:	Tráchtas
Teanga:	English
Foilsithe / Cruthaithe:	2012
Ábhair:	Biology (medical sciences)

Míreanna comhchosúla

Utrophin upregulation and microRNAs - two avenues of Duchenne muscular dystrophy therapy research
de réir: Bareja, A
Foilsithe / Cruthaithe: (2011)

Absence of the dystrophin protein in Duchenne muscular dystrophy: effects on transcriptome, proteome and microRNA secretome
de réir: van Westering, T
Foilsithe / Cruthaithe: (2018)

Therapeutic approaches for Duchenne muscular dystrophy
de réir: Roberts, TC, et al.
Foilsithe / Cruthaithe: (2023)

Liver specific microRNA control of adenovirus serotype five
de réir: Cawood, R
Foilsithe / Cruthaithe: (2011)

Exon skipping peptide-pmos for correction of dystrophin in mouse models of duchenne muscular dystrophy
de réir: Betts, C, et al.
Foilsithe / Cruthaithe: (2014)

Novel miRNA Biomarkers for Patients With Duchenne Muscular Dystrophy
de réir: Qi Meng, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy.
de réir: Goyenvalle, A, et al.
Foilsithe / Cruthaithe: (2011)

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
de réir: Goyenvalle Aurélie, et al.
Foilsithe / Cruthaithe: (2011-02-01)

Motor assessment in patients with Duchenne muscular dystrophy
de réir: Gabriela Palhares Campolina Diniz, et al.
Foilsithe / Cruthaithe: (2012-06-01)

Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy
de réir: Fatima Amor, et al.
Foilsithe / Cruthaithe: (2021-06-01)

Duchenne Muscular Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1989-05-01)

Advances in genetic therapeutic strategies for Duchenne muscular dystrophy
de réir: Guiraud, S, et al.
Foilsithe / Cruthaithe: (2015)

Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy
de réir: Lakshmi Krishna, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
de réir: Addeli Bez Batti Angulski, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
de réir: Cedric Happi Mbakam, et al.
Foilsithe / Cruthaithe: (2022-03-01)

Wharton’s Jelly-Derived Mesenchymal Stem Cells Reduce Fibrosis in a Mouse Model of Duchenne Muscular Dystrophy by Upregulating microRNA 499
de réir: Sang Eon Park, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Biogenesis and function of microRNA miR-124
de réir: Manish Muhuri
Foilsithe / Cruthaithe: (2013)

Muscular Fatigue in Duchenne Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1995-02-01)

Glucocorticoids for Duchenne Muscular Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (2013-07-01)

Theragnosis for Duchenne Muscular Dystrophy
de réir: Leonela Luce, et al.
Foilsithe / Cruthaithe: (2021-06-01)

Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients
de réir: Catapano, F, et al.
Foilsithe / Cruthaithe: (2018)

Development of Therapeutic RNA Manipulation for Muscular Dystrophy
de réir: Saifullah, et al.
Foilsithe / Cruthaithe: (2022-05-01)

MicroRNA detection using carbon nanotubes
de réir: Haja Alaudeen Vajid
Foilsithe / Cruthaithe: (2011)

Progress in therapy for Duchenne muscular dystrophy.
de réir: Fairclough, R, et al.
Foilsithe / Cruthaithe: (2011)

Molecular genetics of Duchenne muscular dystrophy.
de réir: Kunkel, L, et al.
Foilsithe / Cruthaithe: (1986)

Utrophin upregulation in Duchenne muscular dystrophy.
de réir: Hirst, R, et al.
Foilsithe / Cruthaithe: (2005)

Deletion analysis of Duchenne muscular dystrophy
de réir: H Erdem, et al.
Foilsithe / Cruthaithe: (1993-01-01)

Orthopaedic Management in Duchenne Muscular Dystrophy
de réir: Uma Balachandran, BA, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Early Development in Duchenne Muscular Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1990-07-01)

Delay in Diagnosis of Duchenne Muscular Dystrophy
de réir: Vamshi K Rao, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Prednisone-Treated Duchenne Muscular Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (1991-06-01)

Language Delay in Duchenne’s Muscular Dystrophy
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (2007-06-01)

Brain Function in Duchenne Muscular Dystrophy
de réir: J. Gordon Millichap
Foilsithe / Cruthaithe: (2002-02-01)

Epilepsy in Duchenne and Becker muscular dystrophies
de réir: Jesus Alfonso Armijo Gómez, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Cognition trajectory in Duchenne muscular dystrophy
de réir: Abeer A. Tony, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Cardiac therapies for Duchenne muscular dystrophy
de réir: Md Nur Ahad Shah, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Rehabilitation therapy of Duchenne muscular dystrophy
de réir: Cheng ZHANG, et al.
Foilsithe / Cruthaithe: (2012-06-01)

Mortality cost of Duchenne muscular dystrophy
de réir: Erik Landfeldt, et al.
Foilsithe / Cruthaithe: (2017-04-01)

Regenerative biomarkers for Duchenne muscular dystrophy
de réir: Simon Guiraud, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Natural history of Duchenne muscular dystrophy
de réir: Qing KE, et al.
Foilsithe / Cruthaithe: (2015-05-01)